Optinose Us, Inc.

PA · United States · Reporting entity ID 100000011125

Total reported 2019–2025

$15.5M

#383 of 2,960 reporting companies — 0% of all reported industry payments

$9.37M in general payments across 110,777 records, plus $6.08M in research funding across 990 records.

How it breaks down

General payments $9,373,283

Research funding $6,080,587

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.